Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ONTARIO BRAIN INSTITUTE LAUNCHES CENTRE FOR ANALYTICS


TORONTO, April 23, 2024 /CNW/ - The Ontario Brain Institute (OBI) has opened the doors to its new Centre for Analytics with the launch of two transformative, data-driven projects.

"Data connections made possible through the Centre for Analytics will empower neuroscientists and neurotechnology experts to develop new ways of diagnosing and caring for people with brain disorders," said Dr. Tom Mikkelsen, President and Scientific Director of OBI. "This means creating innovative tools for screening risk, even before you know you are at risk, as well as continuous monitoring and feedback to enable people to get and monitor the treatment that they need."

Announced in 2023 with a five million dollar investment from the Government of Ontario, the Centre for Analytics represents an important step in OBI's commitment to translate the innovations that take place in the labs to directly benefit the lives of those living with brain disorders.

Dr. Francis Jeanson, Head of the Centre for Analytics (CfA), suggests that a multi-dimensional approach in neuroanalytics ? training, innovation, and translation ? will accelerate research discoveries, support the development of new treatments and technologies, and improve care for neurological conditions, concussion and brain injuries, and mental health.

"In Canada, and particularly here in Ontario, researchers ? in partnership with patients ? have made significant efforts to collect, de-identify and share health data to amplify neuroscience work across the world," Dr. Jeanson noted. "However, we now find ourselves at a critical point where we need to build up our expertise in complex data analytics, as well as provide training for scientific labs and neurotechnology companies looking to grow and evolve."

To support this pressing need for leadership in analytics, the CfA is focusing on:

Two inaugural analytics initiatives are already leveraging CfA resources and expertise, including data on Brain-CODE, OBI's state-of-the-art neuroinformatics platform, and a new cloud platform that provides advanced computing capabilities and analytical tooling.

The first project, led by Dr. Nardin Samuel of Cove Neurosciences, maps and models multi-modal brain imaging data to better classify neurodevelopment disorders, such as autism and attention-deficit/hyperactivity disorder.

The second initiative, headed by Western University's Dr. Lyle Muller, is developing new, large-scale neural networks that emulate how neurons fire and communicate. Dr. Muller's team is creating these networks to understand how neural circuits generate epilepsy seizures and to help predict if precise timing of non-invasive stimulation can control seizure activity.

"The Ontario Brain Institute's strong line-up of research networks is making amazing progress that is going to make a real difference in the lives of people with Alzheimer's, cerebral palsy and other brain disorders," stated Jill Dunlop, Ontario's Minister of Colleges and Universities. "The new Centre for Analytics will harness the talented Ontario researchers and post-secondary graduates to develop a new generation of analytics and AI tools that will help patients and their families for generations to come."

For more information about OBI's Centre for Analytics, as well as analytics initiatives underway with Dr. Samuel and Dr. Muller, visit braininstitute.ca/cfa.

ABOUT:

The Ontario Brain Institute is a provincially funded, not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. Our collaborative 'team science' approach promotes brain research, commercialization and care by connecting researchers, clinicians, industry, patients, and their advocates to improve the lives of those living with brain disorders.

SOURCE Ontario Brain Institute


These press releases may also interest you

3 mai 2024
Chemistree Technology Inc. and (US OTC: CHMJF) (the "Company" or "Chemistree"), announces that its board of directors (the "Board") has approved a restructuring transaction (the "Restructuring Transaction"), pursuant to which all of the principal of...

3 mai 2024
United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technology, boasting incredible advancements across various fronts, as a Gold sponsor at this year's ISMRM meeting. The...

3 mai 2024
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

3 mai 2024
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

3 mai 2024
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

3 mai 2024
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...



News published on and distributed by: